Cargando…

Exonic CLDN16 mutations associated with familial hypomagnesemia with hypercalciuria and nephrocalcinosis can induce deleterious mRNA alterations

BACKGROUND: Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis type 1 is an autosomal recessive disease characterized by excessive renal magnesium and calcium excretion, bilateral nephrocalcinosis, and progressive chronic renal failure. This rare disease is caused by mutations in CLDN...

Descripción completa

Detalles Bibliográficos
Autores principales: Perdomo-Ramirez, Ana, de Armas-Ortiz, Marian, Ramos-Trujillo, Elena, Suarez-Artiles, Lorena, Claverie-Martin, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325764/
https://www.ncbi.nlm.nih.gov/pubmed/30621608
http://dx.doi.org/10.1186/s12881-018-0713-7
_version_ 1783386183215087616
author Perdomo-Ramirez, Ana
de Armas-Ortiz, Marian
Ramos-Trujillo, Elena
Suarez-Artiles, Lorena
Claverie-Martin, Felix
author_facet Perdomo-Ramirez, Ana
de Armas-Ortiz, Marian
Ramos-Trujillo, Elena
Suarez-Artiles, Lorena
Claverie-Martin, Felix
author_sort Perdomo-Ramirez, Ana
collection PubMed
description BACKGROUND: Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis type 1 is an autosomal recessive disease characterized by excessive renal magnesium and calcium excretion, bilateral nephrocalcinosis, and progressive chronic renal failure. This rare disease is caused by mutations in CLDN16 that encodes claudin-16, a tight-junction protein involved in paracellular reabsorption of magnesium and calcium in the renal tubule. Most of these variants are located in exons and have been classified as missense mutations. The functional consequences of some of these claudin-16 mutant proteins have been analysed after heterologous expression showing indeed a significant loss of function compared to the wild-type claudin-16. We hypothesize that a number of CLDN16 exonic mutations can be responsible for the disease phenotype by disrupting the pre-mRNA splicing process. METHODS: We selected 12 previously described presumed CLDN16 missense mutations and analysed their potential effect on pre-mRNA splicing using a minigene assay. RESULTS: Our results indicate that five of these mutations induce significant splicing alterations. Mutations c.453G > T and c.446G > T seem to inactivate exonic splicing enhancers and promote the use of an internal cryptic acceptor splice site resulting in inclusion of a truncated exon 3 in the mature mRNA. Mutation c.571G > A affects an exonic splicing enhancer resulting in partial skipping of exon 3. Mutations c.593G > C and c.593G > A disturb the acceptor splice site of intron 3 and cause complete exon 4 skipping. CONCLUSIONS: To our knowledge, this is the first report of CLDN16 exonic mutations producing alterations in splicing. We suggest that in the absence of patients RNA samples, splicing functional assays with minigenes could be valuable for evaluating the effect of exonic CLDN16 mutations on pre-mRNA splicing. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12881-018-0713-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6325764
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63257642019-01-11 Exonic CLDN16 mutations associated with familial hypomagnesemia with hypercalciuria and nephrocalcinosis can induce deleterious mRNA alterations Perdomo-Ramirez, Ana de Armas-Ortiz, Marian Ramos-Trujillo, Elena Suarez-Artiles, Lorena Claverie-Martin, Felix BMC Med Genet Research Article BACKGROUND: Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis type 1 is an autosomal recessive disease characterized by excessive renal magnesium and calcium excretion, bilateral nephrocalcinosis, and progressive chronic renal failure. This rare disease is caused by mutations in CLDN16 that encodes claudin-16, a tight-junction protein involved in paracellular reabsorption of magnesium and calcium in the renal tubule. Most of these variants are located in exons and have been classified as missense mutations. The functional consequences of some of these claudin-16 mutant proteins have been analysed after heterologous expression showing indeed a significant loss of function compared to the wild-type claudin-16. We hypothesize that a number of CLDN16 exonic mutations can be responsible for the disease phenotype by disrupting the pre-mRNA splicing process. METHODS: We selected 12 previously described presumed CLDN16 missense mutations and analysed their potential effect on pre-mRNA splicing using a minigene assay. RESULTS: Our results indicate that five of these mutations induce significant splicing alterations. Mutations c.453G > T and c.446G > T seem to inactivate exonic splicing enhancers and promote the use of an internal cryptic acceptor splice site resulting in inclusion of a truncated exon 3 in the mature mRNA. Mutation c.571G > A affects an exonic splicing enhancer resulting in partial skipping of exon 3. Mutations c.593G > C and c.593G > A disturb the acceptor splice site of intron 3 and cause complete exon 4 skipping. CONCLUSIONS: To our knowledge, this is the first report of CLDN16 exonic mutations producing alterations in splicing. We suggest that in the absence of patients RNA samples, splicing functional assays with minigenes could be valuable for evaluating the effect of exonic CLDN16 mutations on pre-mRNA splicing. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12881-018-0713-7) contains supplementary material, which is available to authorized users. BioMed Central 2019-01-08 /pmc/articles/PMC6325764/ /pubmed/30621608 http://dx.doi.org/10.1186/s12881-018-0713-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Perdomo-Ramirez, Ana
de Armas-Ortiz, Marian
Ramos-Trujillo, Elena
Suarez-Artiles, Lorena
Claverie-Martin, Felix
Exonic CLDN16 mutations associated with familial hypomagnesemia with hypercalciuria and nephrocalcinosis can induce deleterious mRNA alterations
title Exonic CLDN16 mutations associated with familial hypomagnesemia with hypercalciuria and nephrocalcinosis can induce deleterious mRNA alterations
title_full Exonic CLDN16 mutations associated with familial hypomagnesemia with hypercalciuria and nephrocalcinosis can induce deleterious mRNA alterations
title_fullStr Exonic CLDN16 mutations associated with familial hypomagnesemia with hypercalciuria and nephrocalcinosis can induce deleterious mRNA alterations
title_full_unstemmed Exonic CLDN16 mutations associated with familial hypomagnesemia with hypercalciuria and nephrocalcinosis can induce deleterious mRNA alterations
title_short Exonic CLDN16 mutations associated with familial hypomagnesemia with hypercalciuria and nephrocalcinosis can induce deleterious mRNA alterations
title_sort exonic cldn16 mutations associated with familial hypomagnesemia with hypercalciuria and nephrocalcinosis can induce deleterious mrna alterations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325764/
https://www.ncbi.nlm.nih.gov/pubmed/30621608
http://dx.doi.org/10.1186/s12881-018-0713-7
work_keys_str_mv AT perdomoramirezana exoniccldn16mutationsassociatedwithfamilialhypomagnesemiawithhypercalciuriaandnephrocalcinosiscaninducedeleteriousmrnaalterations
AT dearmasortizmarian exoniccldn16mutationsassociatedwithfamilialhypomagnesemiawithhypercalciuriaandnephrocalcinosiscaninducedeleteriousmrnaalterations
AT ramostrujilloelena exoniccldn16mutationsassociatedwithfamilialhypomagnesemiawithhypercalciuriaandnephrocalcinosiscaninducedeleteriousmrnaalterations
AT suarezartileslorena exoniccldn16mutationsassociatedwithfamilialhypomagnesemiawithhypercalciuriaandnephrocalcinosiscaninducedeleteriousmrnaalterations
AT claveriemartinfelix exoniccldn16mutationsassociatedwithfamilialhypomagnesemiawithhypercalciuriaandnephrocalcinosiscaninducedeleteriousmrnaalterations